The immune response in tuberculosis.

Annu Rev Immunol 2013 ;31:475-527

Division of Immunoregulation, MRC National Institute for Medical Research, London NW7 1AA, UK.

There are 9 million cases of active tuberculosis reported annually; however, an estimated one-third of the world's population is infected with Mycobacterium tuberculosis and remains asymptomatic. Of these latent individuals, only 5-10% will develop active tuberculosis disease in their lifetime. CD4(+) T cells, as well as the cytokines IL-12, IFN-γ, and TNF, are critical in the control of Mycobacterium tuberculosis infection, but the host factors that determine why some individuals are protected from infection while others go on to develop disease are unclear. Genetic factors of the host and of the pathogen itself may be associated with an increased risk of patients developing active tuberculosis. This review aims to summarize what we know about the immune response in tuberculosis, in human disease, and in a range of experimental models, all of which are essential to advancing our mechanistic knowledge base of the host-pathogen interactions that influence disease outcome.

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-immunol-032712-095939DOI Listing
June 2013
8 Reads

Publication Analysis

Top Keywords

active tuberculosis
12
response tuberculosis
8
mycobacterium tuberculosis
8
immune response
8
tuberculosis
7
risk patients
4
well cytokines
4
patients developing
4
cytokines il-12
4
increased risk
4
associated increased
4
il-12 ifn-γ
4
cells well
4
tuberculosis review
4
disease lifetime
4
aims summarize
4
tuberculosis disease
4
review aims
4
lifetime cd4+
4
cd4+ cells
4

Similar Publications